Clinical trials
Multiple Myeloma trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 7 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Janssen Research & Development, LLC | 4 |
| Bristol-Myers Squibb | 2 |
| Ichnos Sciences SA | 2 |
| Johnson & Johnson Private Limited | 2 |
| Amgen | 1 |
| Baxter Healthcare Corporation | 1 |
| Centocor, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Gleneagles Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 23 |
| Recurrence | 6 |
| Breast Neoplasms | 1 |
| Hematologic Diseases | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.